Waste Management: Why I'm Completely Unshaken

Waste Management is portrayed as fundamentally sound with favorable waste-generation trends underpinning its legacy business and a strategic Healthcare push expected to accelerate growth; however recycled commodity price weakness has pressured revenue and near-term guidance. The author expects 2025 to be stronger than 2024, views the recent valuation contraction as a buying opportunity, and reiterates a bullish stance despite the stock underperforming since an early‑August buy recommendation.

Analysis

Market structure: Waste Management (WM) benefits directly from secular waste generation and scale advantages—its legacy collection/landfill cashflows are defensive and gain pricing power versus smaller haulers. Downside pressure from recycled-commodity prices mainly hurts revenues in the recycling funnel and independent brokers, compressing near-term top-line but not core collection EBITDA if fuel/labor remain stable. Cross-asset: WM behaves bond-like; widening equity sell-offs should push credit spreads and implied equity volatility higher, while muni/recycling commodity prices (paper/plastics) drive short-term revenue swings.

Risk assessment: Tail risks include regulatory shifts (extended producer responsibility or landfill bans) that could force material capex or margin pressure (impact >5-10% EBITDA in adverse scenarios), operational accidents at facilities, or healthcare integration missteps. Immediately (days) expect EPS guidance volatility and IV spikes around earnings; in 3–6 months recycled-commodity normalization or further weakness will determine revenue trajectory; in 6–24 months healthcare vertical execution will determine re-rating potential. Hidden dependencies include third-party commodity markets, labor contracts, and M&A pace; catalysts are Q3/Q4 earnings, commodity price rebounds, and any analyst upgrades.

Trade implications: Consider establishing a 2–3% long position in WM now (ticker WM) and add to size on a >10% pullback or if recycled-commodity indices recover 15% within 3–6 months. Pair trade: long WM vs short RSG (Republic Services) at a 1:1 notional if WM guidance shows faster healthcare-led growth; options: buy 12-month LEAP calls (delta ~0.40) or sell cash-secured put spreads (strike ~5–10% below today) to collect premium while targeting entry. Rotate: overweight waste services and utilities, trim cyclical industrial exposure by 2–4% of portfolio; take partial profits at +20–30% or upon a sustained guidance reset downward.

Contrarian angles: Consensus may be overpricing permanent damage from recycled-commodity weakness; the market underestimates WM’s pricing/volume elasticity and healthcare TAM that could add 1–2 turns of multiple if execution proves out in 12–24 months. Historical parallels (post-2016 recyclables slump) show cyclical revenue recovery within 6–12 months—if that repeats, short-term pain is a buying window. Unintended consequence: a sharp commodity rebound could invite aggressive pricing by smaller players, so monitor margin trends and spread between collection and recycling margins before scaling exposure.

Key Decisions for Investors

• Establish an initial 2–3% long position in WM (Waste Management) today; plan to add an equal amount if the stock falls >10% or if recycled-commodity price indices recover by >=15% within 3–6 months.
• Implement a pair trade: long WM vs short RSG (Republic Services) 1:1 notional size to express belief in WM's healthcare-driven re-rating; reduce or unwind if relative performance diverges by >15% or if WM guidance deteriorates again.
• Use options to express asymmetric upside: buy 12-month LEAP calls on WM (target delta ~0.40) financed by selling 3-month covered calls or put spreads with strikes 5–10% below current levels to lower cost basis; reassess ahead of quarterly earnings to avoid IV spikes.
• Rotate portfolio: overweight waste services (WM, RSG) and utilities by +2–4% against cyclicals; trim industrials/ex-ESG cyclic exposure where margin cyclicality exceeds 10% of EBITDA risk.
• Set hard exit/scale rules: take 50% profits on any WM position at +20% and fully realize at +30%; cut loss if WM revises full-year EBITDA guidance down by >5% or if healthcare integration misses defined milestones over 12 months.